Recurium Equity, LLC 3

3 · Zentalis Pharmaceuticals, LLC · Filed Apr 3, 2020

Insider Transaction Report

Form 3
Period: 2020-04-03
Holdings
  • Common Stock

    4,162,930

Documents

2 files